The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2

Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study

(2014) Darrell H S Tan et al.   BMJ Open

Herpes Simplex Virus Type 2 Coinfection Does Not Accelerate CD4 Count Decline in Untreated HIV Infection

(2013) Darrell H. S. Tan et al.   CLINICAL INFECTIOUS DISEASES

A Randomized Controlled Pilot Trial of Valacyclovir for Attenuating Inflammation and Immune Activation in HIV/Herpes Simplex Virus 2–Coinfected Adults on Suppressive Antiretroviral Therapy

(2013) Tae Joon Yi et al.   CLINICAL INFECTIOUS DISEASES

Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial

(2013) Andrew Mujugira et al.   JOURNAL OF INFECTIOUS DISEASES

Serologic Screening for Herpes Simplex Virus Type 2 in Persons With Human Immunodeficiency Virus

(2012) Nicholas J. Van Wagoner et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Type-Specific Identification of Anogenital Herpes Simplex Virus Infections by Use of a Commercially Available Nucleic Acid Amplification Test

(2012) B. Van Der Pol et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial

(2012) Steven J Reynolds et al.   LANCET INFECTIOUS DISEASES

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes

(2011) David W. Kimberlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost Ramifications of Increased Reporting of Detectable Plasma HIV-1 RNA Levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 Version 1.0 Viral Load Test

(2010) James H Willig et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

(2010) Jairam R Lingappa et al.   LANCET

Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2

(2010) C. Celum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay

(2009) Viviane Lima et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Factors Associated with the Prevalence and Incidence of Herpes Simplex Virus Type 2 Infection among Men in Rakai, Uganda

(2009) Aaron A. R. Tobian et al.   JOURNAL OF INFECTIOUS DISEASES

Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition

(2009) Jia Zhu et al.   NATURE MEDICINE

Detection of HIV Type 1 Load by the Roche Cobas TaqMan Assay in Patients with Viral Loads Previously Undetectable by the Roche Cobas Amplicor Monitor

(2008) Hiroyuki Gatanaga et al.   CLINICAL INFECTIOUS DISEASES

Rapidly Cleared Episodes of Herpes Simplex Virus Reactivation in Immunocompetent Adults

(2008) Karen E. Mark et al.   JOURNAL OF INFECTIOUS DISEASES

Herpes Simplex Virus (HSV)–Suppressive Therapy Decreases Plasma and Genital HIV‐1 Levels in HSV‐2/HIV‐1 Coinfected Women: A Randomized, Placebo‐Controlled, Cross‐Over Trial

(2008) Jared M. Baeten et al.   JOURNAL OF INFECTIOUS DISEASES